SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001206774-21-001101
Filing Date
2021-04-13
Accepted
2021-04-13 16:31:39
Documents
10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS bmrn3796953-defa14a.htm DEFA14A 42354
2 GRAPHIC bmrn3796953-def14alogo.jpg GRAPHIC 31885
3 GRAPHIC bmrn3796953-defa14ax1x1.jpg GRAPHIC 10788
4 GRAPHIC bmrn3796953-defa14ax1x2.jpg GRAPHIC 4919
5 GRAPHIC bmrn3796953-defa14ax1x3.jpg GRAPHIC 4559
6 GRAPHIC bmrn3796953-defa14ax1x4.jpg GRAPHIC 5694
7 GRAPHIC bmrn3796953-defa14ax1x5.jpg GRAPHIC 4960
8 GRAPHIC bmrn3796953-defa14ax1x6.jpg GRAPHIC 5487
9 GRAPHIC bmrn3796953-defa14ax1x7.jpg GRAPHIC 35886
10 GRAPHIC bmrn3796953-defa14ax2x1.jpg GRAPHIC 1075
  Complete submission text file 0001206774-21-001101.txt   189655
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26727 | Film No.: 21823390
SIC: 2834 Pharmaceutical Preparations